急性照护中患者层面抗菌药物管理干预效果评估指标的专家共识
抗菌药物管理项目(ASP)对患者照护有积极影响,但评估ASP效果的指标定义不清。
要点
- 6个指标在所有评估标准上评分均>6,可用于评估患者层面ASP干预效果。
- 这6个指标包括2个艰难梭菌感染发病率指标、耐药病原体发病率、每入院日治疗天数、每患者日治疗天数及重复治疗事件。
核心结论
- 确定了6个可用于评估急性照护中患者层面抗菌药物管理干预效果的指标,这些指标在改善处方、改善患者照护、针对管理工作的实用性和电子健康记录医院的可行性上均评分>6。
研究设计与样本
- 采用改良德尔菲法,专家小组对90个候选指标在9点李克特量表上就4项标准进行评分,并通过结构化电话会议进一步优化指标。
主要发现
- 6个指标在所有4项标准上评分均>6,包括2个艰难梭菌感染发病率指标、耐药病原体发病率、每入院日治疗天数、每患者日治疗天数及重复治疗事件。
关键数值与推荐
- 6个指标在改善抗菌药物处方、改善患者照护、针对管理工作的实用性和电子健康记录医院的可行性上评分均>6。
临床怎么用
- 这些指标可用于急性照护机构内部项目决策,评估患者层面抗菌药物管理干预的效果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Antimicrobial stewardship programs (ASPs) positively impact patient care, but metrics to assess ASP impact are poorly defined. We used a modified Delphi approach to select relevant metrics for assessing patient-level interventions in acute-care settings for the purposes of internal program decision making. An expert panel rated 90 candidate metrics on a 9-point Likert scale for association with 4 criteria: improved antimicrobial prescribing, improved patient care, utility in targeting stewardship efforts, and feasibility in hospitals with electronic health records. Experts further refined, added, or removed metrics during structured teleconferences and re-rated the retained metrics. Six metrics were rated >6 in all criteria: 2 measures of Clostridium difficile incidence, incidence of drug-resistant pathogens, days of therapy over admissions, days of therapy over patient days, and redundant therapy events. Fourteen metrics rated >6 in all criteria except feasibility were identified as targets for future development.
引用
- Moehring RW, Anderson DJ, Cochran RL, et al. Expert Consensus on Metrics to Assess the Impact of Patient-Level Antimicrobial Stewardship Interventions in Acute-Care Settings. Clin Infect Dis. 2016. PMID: 27927866. doi:10.1093/cid/ciw787
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。